Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

Recent Healthcare Stocks Articles

Why Is Moderna (MRNA) Stock Up 11% Today?

Moderna stock is on the rise Thursday as investors in MRNA react to positive results from a skin cancer vaccine in a Phase 2b trial.

The 7 Most Undervalued Cannabis Stocks to Buy in December

These seven cannabis stocks are either undervalued based on traditional metrics, or are undervalued relative to future potential.

3 AI and Robotics Stocks Reshaping the Future of Tech

Through the pulsating realms of technology and healthcare, this article unveils the captivating narratives of three visionary entities.

3 Biotech Stocks With Promising Pipelines and Big Growth Potential in 2024

These biotech stocks with promising pipelines are showing some major promise and growth potential for the new year.

3 Stocks to Ride the Latin America Market Boom in 2024

Thanks to these three companies, Latin America stocks could be the big winners in the emerging markets in 2024.

Why Is SciSparc (SPRC) Stock Up 25% Today?

With SciSparc announcing positive results stemming from its joint venture, the drug discovery implications are boosting SPRC stock.

Rescheduling & Legalization: 7 Cannabis Stocks Set to Surge in 2024

Wager on these top cannabis stocks for 2024, fueled by policy shifts and public opinion offering strong upside

Next Wave Biotech: 3 Stocks Poised for Breakthrough Success

The overall sector may be struggling after COVID, but there's still great potential in these three biotech stocks.

Why Is Canopy Growth (CGC) Stock Down 25% Today?

The dreams of an unlimited legal market for marijuana have gone up in smoke, and investors are paying a price.

Why Is Shattuck Labs (STTK) Stock Up 93% Today?

Shattuck Labs stock is rising on Wednesday after the company provided positive initial results from a Phase 1 clinical trial.

Why Is ReShape Lifesciences (RSLS) Stock Up 68% Today?

ReShape Lifesciences stock is rising with heavy trading of RSLS shares alongside an update from the FDA concerning its weight loss products.

Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today?

Pasithea Therapeutics stock is falling on Wednesday after shares of KTTA underwent extreme volatility yesterday on study results.

Seeking Passive Income? 7 Dividend Stocks You Don’t Want to Miss.

The quest for stable investment avenues beckons toward dividend stocks, offering a beacon of financial security and passive income.

3 Gene-Editing Stocks With the Potential to Mint Millionaires

Gene editing stocks are very likely to see a spike in demand over the coming weeks in the wake of FDA approval of CRISPR.

Why Is Cassava Sciences (SAVA) Stock Up 15% Today?

Although Cassava Sciences’ issuance of warrants presents risks, the underlying Phase 3 trial support boosted SAVA stock.

3 Useless Stocks to Sell in 2023 to Reduce Your Taxes in 2024

Run, don't walk, from these chronically underperforming stocks, each of which has long-term structural problems.

Why Is Evofem (EVFM) Stock Up 85% Today?

Here's one under-the-radar penny stock that investors are buying up big today. But the question is, why is EVFM stock surging?

Why Is Aditxt (ADTX) Stock Up 58% Today?

Aditxt stock is up on Tuesday as investors in ADTX shares react to the company announcing plans to acquire Evofem Biosciences.

Why Is C4 Therapeutics (CCCC) Stock Up 72% Today?

C4 Therapeutics stock is rising higher on Tuesday as investors in CCCC shares celebrate a new collaboration agreement with Merck.